BR9815983A - Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancer - Google Patents
Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancerInfo
- Publication number
- BR9815983A BR9815983A BR9815983-6A BR9815983A BR9815983A BR 9815983 A BR9815983 A BR 9815983A BR 9815983 A BR9815983 A BR 9815983A BR 9815983 A BR9815983 A BR 9815983A
- Authority
- BR
- Brazil
- Prior art keywords
- tumor
- human
- elicit
- cancer
- composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"PROCESSOS PARA TRATAR CâNCER SELECIONADO DENTRE O GRUPO CONSISTINDO DE ADENOCARCINOMA E LEUCEMIA, PARA ELICIAR LINFóCITOS T PARA INFILTRAR UM TUMOR DE UM HUMANO, PARA ELICIAR UMA RESPOSTA INFLAMATóRIA A UM TUMOR DE UM HUMANO, PARA ELICIAR UMA RESPOSTA DE HIPERSENSIBILIDADE DE TIPO RETARDADO A UM TUMOR DE UM HUMANO, E, COMPOSIçãO PARA O TRATAMENTO DE CâNCER". A presente invenção é dirigida a composições e processos para o tratamento de câncer. As composições da presente invenção incluem uma composição preparada a partir de uma célula de tumor que é modificada por hapteno e singeneica para o tipo de tumor a ser tratado. A composição tem as propriedades, quando administrada com um adjuvante a um humano sofrendo de um tumor maligno do mesmo tipo que referida célula de tumor, de eliciar linfócitos T que infiltram o tumor do referido humano, de eliciar uma resposta imune inflamatória contra o tumor do referido humano, e de eliciar uma resposta de hipersensibilidade de tipo retardado para o tumor do referido humano. Os processos da presente invenção são dirigidos ao tratamento de câncer compreendendo a administração de uma quantidade terapeuticamente efetiva de uma composição compreendendo uma célula de tumor."PROCESSES TO TREAT SELECTED CANCER FROM THE GROUP CONSISTING OF ADENOCARCINOMA AND LEUKEMIA, TO ELECT TYPE LYMPHOCYTES TO INFILTRATE A TUMOR IN A HUMAN, TO ELICIATE AN INFLAMMATORY RESPONSE TO A TUMOR OF A HUMAN, HYPICAL HYPOTHYLES, A HYPER HUMIDITY TUMOR OF A HUMAN, AND, COMPOSITION FOR THE TREATMENT OF CANCER ". The present invention is directed to compositions and processes for the treatment of cancer. The compositions of the present invention include a composition prepared from a tumor cell that is modified by hapten and syngeneic for the type of tumor to be treated. The composition has the properties, when administered with an adjuvant to a human suffering from a malignant tumor of the same type as said tumor cell, to elicit T lymphocytes that infiltrate the tumor of said human, to elicit an inflammatory immune response against the tumor of the human said human, and to elicit a delayed type hypersensitivity response to said human tumor. The processes of the present invention are directed to the treatment of cancer comprising administering a therapeutically effective amount of a composition comprising a tumor cell.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR9815983-6A BR9815983A (en) | 1998-08-10 | 1998-08-10 | Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancer |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/016660 WO2000009140A1 (en) | 1997-07-24 | 1998-08-10 | Composition and method of using tumor cells |
| BR9815983-6A BR9815983A (en) | 1998-08-10 | 1998-08-10 | Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815983A true BR9815983A (en) | 2002-01-02 |
Family
ID=4071657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815983-6A BR9815983A (en) | 1998-08-10 | 1998-08-10 | Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancer |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR9815983A (en) |
-
1998
- 1998-08-10 BR BR9815983-6A patent/BR9815983A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL138723A0 (en) | Antitumor agent | |
| DK0490077T3 (en) | Antisense oligonucleotides for the treatment of cancer | |
| NO169291C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAPYRROL-AMINO-DICARBOXYLIC ACID ADD | |
| MY112405A (en) | Method of tumer treatment. | |
| BR0115260A (en) | Sn-38 lipid complexes and their uses in treating diseases | |
| MX9703621A (en) | Novel amino acid derivatives with improved multi-drug resistance activity. | |
| NZ258019A (en) | Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract | |
| CA2337205A1 (en) | Treatment of skin disorders | |
| UA72909C2 (en) | Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives | |
| BR0206046A (en) | Uses of a combination of protopanaxadiol sapogenin or protopanaxatriol sapogenin, and, pharmaceutical composition | |
| JPS5735516A (en) | Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation | |
| BR9910187A (en) | Process and composition for inducing an anti-tumor response in a mammalian patient suffering from a tumor | |
| HK1033910A1 (en) | Use of erythropoietin in the treatment of multiple myeloma | |
| AU1206292A (en) | Therapeutic agents for the treatment of multidrug resistance to cancers | |
| JP2002511419A5 (en) | ||
| WO2003017939A3 (en) | Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment | |
| IL141550A0 (en) | Methods and compositions for the prevention or treatment of cancer | |
| IL114382A (en) | Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament | |
| DE60230155D1 (en) | USE OF BRANCHED FATTY ACIDS AND ITS DERIVATIVES FOR PAIN TREATMENT | |
| BR9907912A (en) | Composition, processes to treat cancer, to elicit T lymphocytes that infiltrate a mammalian tumor, to elicit a delayed hypersensitivity response to a mammalian tumor, and to prepare hapten-modified tumor cell membranes, and, isolated membrane of mammalian tumor cell | |
| BR9815983A (en) | Processes for treating selected cancer from the group consisting of adencarcinoma and leukemia, to elicit t-lymphocytes to infiltrate a human tumor, to elicit an inflammatory immune response to a human tumor, to elicit a delayed type hypersensitivity response to a tumor of a human, and, composition for the treatment of cancer | |
| IL112963A0 (en) | A pharmaceutical composition containing gamma globulins or fragments thereof | |
| DE69814691D1 (en) | USE OF FC101 AS AN INGIOGENESE TREATMENT FOR TREATING CANCER AND OTHER ANGIOGENIC DISEASES | |
| CN104983676A (en) | Fullerene injection | |
| Song et al. | Preparation and properties of medical compound hemostasis dressing from Pacific cod skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/12, A61K 35/26, A61K 35/28, C12N 5/08, C12N 15/01 Ipc: A61K 35/13 (2015.01), C12N 15/01 (2006.01), C12N 5 |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/13 (2015.01), C12N 5/09 (2010.0 |